Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma Journal Article


Authors: Tilly, H.; Morschhauser, F.; Sehn, L. H.; Friedberg, J. W.; Trnĕný, M.; Sharman, J. P.; Herbaux, C.; Burke, J. M.; Matasar, M.; Rai, S.; Izutsu, K.; Mehta-Shah, N.; Oberic, L.; Chauchet, A.; Jurczak, W.; Song, Y.; Greil, R.; Mykhalska, L.; Bergua-Burgués, J. M.; Cheung, M. C.; Pinto, A.; Shin, H. J.; Hapgood, G.; Munhoz, E.; Abrisqueta, P.; Gau, J. P.; Hirata, J.; Jiang, Y.; Yan, M.; Lee, C.; Flowers, C. R.; Salles, G.
Article Title: Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma
Journal Title: New England Journal of Medicine
Volume: 386
Issue: 4
ISSN: 0028-4793
Publisher: Massachusetts Medical Society  
Date Published: 2022-01-27
Start Page: 351
End Page: 363
Language: English
DOI: 10.1056/NEJMoa2115304
PROVIDER: EBSCOhost
PROVIDER: cinahl
PUBMED: 34904799
PMCID: PMC11702892
DOI/URL:
Notes: Accession Number: 154962352 -- Entry Date: 20220202 -- Revision Date: 20220211 -- Publication Type: Article -- Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 0255562. -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew J Matasar
    290 Matasar
  2. Gilles Andre Salles
    272 Salles